TSX:BHC (Bausch Health Companies Inc.)

About BHC

Bausch Health Companies Inc. is a global company that develops manufactures and markets a range of pharmaceutical medical device and over-the-counter products primarily in the therapeutic areas of eye health gastroenterology and dermatology. We are delivering on our commitments as we build an innovative company dedicated to advancing global health. Our approximately 22000 employees are united around our mission of improving peoples lives with our health care products and we manufacture and market health care products directly or indirectly in approximately 100 countries. Five pillars or guiding principles represent the foundation on which we are realizing our mission as an organization: People Quality Health Care Outcomes Customer Focus Innovation and Efficiency.
  • Bausch Health Companies Inc. (TSX: BHC) Latest News

    The Motley Fool
    Investing

    Why Did Concordia Healthcare Corp. Shares Fall 50%?

    Concordia Healthcare Corp. (TSX:CXR)(NYSE:CXRX) shares have fallen by 50% since September 8th. Is this the opportunity of a lifetime?

    Read more »

    The Motley Fool
    Investing

    These 2 Oversold Healthcare Stocks Are too Cheap to Ignore Any Longer

    Concordia Healthcare Corp. (TSX:CXR)(NASDAQ:CXRX) and Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) are oversold and could generate huge returns going forward. Which…

    Read more »

    The Motley Fool
    Investing

    Are Valeant Pharmaceuticals Intl Inc. and Concordia Healthcare Corp. Bargains After Crashing?

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) and Concordia Healthcare Corp. (TSX:CXR)(NYSE:CXRX) have seen their share prices absolutely plunge.

    Read more »

    The Motley Fool
    Investing

    Is Valeant Pharmaceuticals Intl Inc.’s 34% Decline an Opportunity to Buy?

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) has fallen 34% in two months. Is the high-growth pharmaceutical company a bargain or should…

    Read more »

    The Motley Fool
    Investing

    Concordia Healthcare Corp. and Valeant Pharmaceuticals Intl Inc. Suffer Big Declines

    The Democrats have their eyes on limiting drug-price increases. It's good for patients, but not so much for Valeant Pharmaceuticals…

    Read more »

    The Motley Fool
    Investing

    4 Dirty Secrets Bay Street Bankers Don’t Want You to Know

    Find out why you should be very wary of what Bay Street tells you, using Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX)…

    Read more »

    The Motley Fool
    Investing

    Should the Recession News Change Your Investing Strategy?

    The answer to Canada's recession is a properly diversified portfolio. This may mean reducing commodity names like Canadian Oil Sands…

    Read more »

    The Motley Fool
    Investing

    3 Growth Stocks for a Low-Growth Economy

    Canadian and global growth is slowing. Fortunately, you can still find growth in stocks like Agrium Inc. (TSX:AGU)(NYSE:AGU), CGI Group…

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc. Continues to Impress With Another Acquisition

    While the market is experiencing a downturn period of slowness, Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) continues to grow.

    Read more »

    The Motley Fool
    Investing

    Is Valeant Pharmaceuticals Intl Inc. a Buy on Recent Acquisition News?

    Buying Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) on its acquisition news is a smart investment because often when it buys new…

    Read more »

    The Motley Fool
    Dividend Stocks

    Steal These 3 Investing Tips From 1 of Canada’s Best Investors

    There are many lessons to be learned from Stephen Jarislowsky, one of Canada's greatest investors. Here's why he'd avoid Valeant…

    Read more »

    Investing

    3 Secular Trends Every Canadian Investor Should Know

    Benefit from these secular trends by investing in BCE Inc. (TSX:BCE)(NYSE:BCE), Brookfield Renewable Energy Partners L.P. (TSX:BEP.UN)(NYSE:BEP), and Valeant Pharmaceuticals…

    Read more »